You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm, cofounded by several Harvard University researchers, is commercializing a single-cell spatial transcriptomics technology called MERFISH.
Researchers found sub-chromosomal aneuploidy, DNA damage pathway changes, and other somatic changes in breast cells from BRCA2 mutation carriers.
In Cell this week: a quantitative proteomic atlas based on the Cancer Cell Line Encyclopedia, gene regulation and differentiation in Toxoplasma gondii, and more.
A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.
10x Genomics sued Harvard University and 1CellBio, a competing single-cell technology firm, in 2018 over licenses for patents granted to both companies.
The genomes of four children who died in Cameroon 3,000 to 8,000 years ago pointed to diverse early lineages and helped tease out historical population relationships.
Having raised $1.5 million in funding since announcing the project at a 2017 AACR meeting, the group anticipates completing the first phase of the project by Q2 2020.
Illumina, Twist Bioscience, and DNA Script are among the private sector collaborators of the groups receiving funds to develop technology platforms.
In Nature this week: computational approach to find mosaic mutations in sequencing data, and more.
In PLOS this week: consequences of double-strand DNA break repair in E. coli, KRAS mutations in circulating tumor DNA samples, and more.
Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.
Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.
Stat News reports some health tech startups are laying off or furloughing workers.
In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.